ATE350045T1 - Verwendung einer zusammensetzung mit einem prebiotischen mittel zur reduzierung des entzündlichen prozesses und der abnormalen aktivierung unspezifischer immunparameter - Google Patents

Verwendung einer zusammensetzung mit einem prebiotischen mittel zur reduzierung des entzündlichen prozesses und der abnormalen aktivierung unspezifischer immunparameter

Info

Publication number
ATE350045T1
ATE350045T1 AT02726177T AT02726177T ATE350045T1 AT E350045 T1 ATE350045 T1 AT E350045T1 AT 02726177 T AT02726177 T AT 02726177T AT 02726177 T AT02726177 T AT 02726177T AT E350045 T1 ATE350045 T1 AT E350045T1
Authority
AT
Austria
Prior art keywords
reduce
composition containing
specific immune
inflammatory process
abnormal activation
Prior art date
Application number
AT02726177T
Other languages
English (en)
Inventor
Florence Rochat
Eduardo Schiffrin
Yves Guigoz
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8180054&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE350045(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of ATE350045T1 publication Critical patent/ATE350045T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/42—Dry feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Pediatric Medicine (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physiology (AREA)
  • Transplantation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02726177T 2001-03-22 2002-03-15 Verwendung einer zusammensetzung mit einem prebiotischen mittel zur reduzierung des entzündlichen prozesses und der abnormalen aktivierung unspezifischer immunparameter ATE350045T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01201091A EP1243273A1 (de) 2001-03-22 2001-03-22 Zubereitung enthaltend einen praebiotischen Stoff für die Behandlung von Entzündungen und abnormale Aktivierung von nicht-spezifischen immunologischen Parametern

Publications (1)

Publication Number Publication Date
ATE350045T1 true ATE350045T1 (de) 2007-01-15

Family

ID=8180054

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02726177T ATE350045T1 (de) 2001-03-22 2002-03-15 Verwendung einer zusammensetzung mit einem prebiotischen mittel zur reduzierung des entzündlichen prozesses und der abnormalen aktivierung unspezifischer immunparameter

Country Status (14)

Country Link
US (1) US8092608B2 (de)
EP (2) EP1243273A1 (de)
JP (1) JP4456329B2 (de)
CN (1) CN1738595B (de)
AR (1) AR033439A1 (de)
AT (1) ATE350045T1 (de)
CA (1) CA2442053C (de)
DE (1) DE60217319T3 (de)
EA (1) EA006441B1 (de)
ES (1) ES2278021T5 (de)
PE (1) PE20020986A1 (de)
UY (1) UY27221A1 (de)
WO (1) WO2002076471A1 (de)
ZA (1) ZA200308189B (de)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
WO2003088984A1 (en) 2002-03-13 2003-10-30 Kibow Biotech Inc. Compositions and methods for augmenting kidney function
ES2355890T3 (es) * 2002-04-05 2011-04-01 Societe des Produits Nestlé S.A. Composiciones y métodos para promocionar la asimilación de lípidos en los animales domésticos.
AU2003245156A1 (en) * 2002-06-21 2004-01-06 Canacure Corporation Liquid compositions comprising non-digestible oligosaccharides and green tea catechins, method and uses thereof
US20090022852A1 (en) * 2002-06-21 2009-01-22 Dnp Canada Inc. Liquid Compositions Comprising Non-Digestible Oligosaccharides and Green Tea Catechins
ATE430802T1 (de) 2003-08-21 2009-05-15 Monsanto Technology Llc Fettsäuredesaturasen aus primula
US7118772B2 (en) * 2003-09-18 2006-10-10 General Mills, Inc. Inulin infused fruit and method of preparation
US20050119222A1 (en) 2003-12-01 2005-06-02 The Iams Company Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use
NO320546B1 (no) * 2003-12-12 2005-12-19 Nova Biotics As Prebiotiske kombinasjonsprodukter
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
BRPI0509944A (pt) 2004-04-16 2007-09-25 Monsanto Technology Llc expressão de dessaturases de ácido graxo em milho
EP1597978A1 (de) 2004-05-17 2005-11-23 Nutricia N.V. Synergie von GOS und polyfruktose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
US7862808B2 (en) * 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
WO2006012536A2 (en) 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
FR2877844B1 (fr) * 2004-11-18 2008-05-09 United Pharmaceuticals Sa Sa Composition contenant un probiotique destinee a l'alimentation infantile chez des sujets souffrant de diarrhees
US7303745B2 (en) * 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
AU2006253007B2 (en) 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
EP2261323A1 (de) 2005-05-31 2010-12-15 The Iams Company Probiotische Katzen-Laktobazillen
US7572474B2 (en) * 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
HUP0500582A1 (hu) * 2005-06-13 2007-08-28 Csaba Jozsef Dr Jaszberenyi Szinergetikus élettani hatású élelmiszerek, élelmiszer-adalékok és táplálék-kiegészítõk vagy takarmányadalékok
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
US8287931B2 (en) 2005-06-30 2012-10-16 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
EP1931363B1 (de) 2005-09-28 2015-11-18 Nordisk Rebalance A/S Behandlung von entzündlicher darmerkrankung mit probiotischen bakterien und fermentierten cerealien als behandlungseffektoren
EP1946651B1 (de) 2005-10-18 2011-03-23 Kao Corporation Haustierfutter
RU2395218C2 (ru) 2005-10-24 2010-07-27 Нестек С.А. Композиция пищевых волокон для профилактики или лечения заболеваний пищеварительной системы и композиция пищевых волокон, эффективная при лечении холеры
RU2448720C2 (ru) 2006-03-07 2012-04-27 Нестек С.А. Синбиотическая смесь
US20100092429A1 (en) * 2006-12-11 2010-04-15 Danisco A/S Composition
RU2436581C2 (ru) 2007-02-01 2011-12-20 Дзе Иамс Компани Способ уменьшения воспаления и снижения стресса у млекопитающего
US9771199B2 (en) * 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
MX2011002735A (es) * 2008-09-11 2011-04-12 Iams Company Alimento granulado para animales que tiene un nucleo basado en proteinas y metodos relacionados.
US8986769B2 (en) * 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
US8425955B2 (en) 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
EP2400839B1 (de) 2009-02-24 2016-09-07 Ritter Pharmaceuticals, Inc. Präbiotische formulierungen und verwendungsverfahren dafür
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
WO2011060123A1 (en) 2009-11-12 2011-05-19 Nestec S.A. Nutritional composition for promoting gut microbiota balance and health
EP3202406A1 (de) 2010-04-28 2017-08-09 Ritter Pharmaceuticals, Inc. Präbiotische formulierungen und deren verwendungen
BR112013004194A2 (pt) * 2010-08-25 2016-05-10 Tate & Lyle Ingredients produto simbiótico
DE102011052687A1 (de) 2011-08-12 2013-02-14 Lohmann Animal Health Gmbh Verwendung von Antioxidantien
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
WO2014007606A1 (en) 2012-07-05 2014-01-09 N.V. Nutricia Product for use in the prophylactic or therapeutic treatment of a negative emotion or introvert behaviour
GB201312713D0 (en) * 2013-03-22 2013-08-28 Weaver Connie M Uses of soluble corn fibre for increasing colonic bacteria populations and increasing mineral absorption
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
EP3400953A1 (de) 2014-12-23 2018-11-14 4D Pharma Research Limited Pirinpolypeptid und immunmodulation
AR103260A1 (es) 2014-12-23 2017-04-26 4D Pharma Res Ltd Modulación inmunitaria
CA2983236A1 (en) * 2015-04-23 2016-10-27 Kaleido Biosciences, Inc. Glycan therapeutics and methods of treatment
NZ737752A (en) 2015-06-15 2022-02-25 4D Pharma Res Ltd Compositions comprising bacterial strains
WO2016203221A1 (en) 2015-06-15 2016-12-22 4D Pharma Research Limited Compositions comprising bacterial strains
SMT201900588T1 (it) 2015-06-15 2019-11-13 4D Pharma Res Limited Blautia stercoris e wexlerae per uso nel trattamento di malattie infiammatorie ed autoimmuni
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
CN108513545B (zh) 2015-11-20 2020-11-03 4D制药研究有限公司 包含细菌菌株的组合物
ME03487B (de) 2016-03-04 2020-01-20 4D Pharma Plc Zusammensetzungen mit bakteriellen blautia-stämmen zur behandlung von viszeraler überempfindlichkeit
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
TWI802545B (zh) 2016-07-13 2023-05-21 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
MX2018015344A (es) 2016-12-15 2019-04-29 Nestec Sa Composiciones y metodos que modulan las bacterias en un animal de compañía.
DK3630136T3 (da) 2017-05-22 2021-05-25 4D Pharma Res Ltd Sammensætninger, der omfatter bakteriestammer
EP3630942B1 (de) 2017-05-24 2022-11-30 4D Pharma Research Limited Zusammensetzungen mit bakterienstamm
SMT202000555T1 (it) 2017-06-14 2020-11-10 4D Pharma Res Limited Composizioni comprendenti un ceppo batterico del genere megaspaera e loro usi
CA3066189A1 (en) 2017-06-14 2018-12-20 4D Pharma Research Limited Compositions comprising bacterial strains
SMT202000695T1 (it) 2017-06-14 2021-01-05 4D Pharma Res Limited Composizioni comprendenti ceppi batterici
WO2019136236A1 (en) * 2018-01-04 2019-07-11 White Dog Labs, Inc. Method and composition for improving health of an animal comprising cells of organism consisting of the strains within the order clostridiales
CN110279117A (zh) * 2018-03-19 2019-09-27 医迈霖科技公司 一种益生菌冻干食品
CN112616925A (zh) * 2020-12-30 2021-04-09 光明乳业股份有限公司 一种双蛋白发酵乳及其制备方法
CN114099408A (zh) * 2021-09-23 2022-03-01 仙婷(广州)科技研发有限公司 一种含有益生元、益生菌和后生元的组合物及其制备方法
US12343366B2 (en) * 2021-11-05 2025-07-01 Tci Co., Ltd. Prebiotic composition and method for improving intestinal health using the same

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5531989A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
ATE232389T1 (de) † 1995-04-05 2003-02-15 Abbott Lab Inhibierung von c. difficile-infektionen mit unverdaulichen oligosacchariden
US5849324A (en) * 1995-07-10 1998-12-15 Abbott Laboratories Use of indigestible oligosaccharides to reduce the incidence of otitis media in humans
AU1854297A (en) * 1996-02-14 1997-09-02 Procter & Gamble Company, The Urogenital and intestinal disorder compositions comprising substance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor
ATE169456T1 (de) * 1996-12-23 1998-08-15 Sitia Yomo Spa Lyophilisierte, lebende bakerien enthaltende nahrungszusammensetzung
FI107014B (fi) * 1997-07-25 2001-05-31 Oriola Oy Terveysravintovalmiste
US6203797B1 (en) * 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome
US6130244A (en) * 1998-02-25 2000-10-10 Abbott Laboratories Product and method to reduce stress induced immune suppression
CN1273039A (zh) * 1999-05-06 2000-11-15 四川禾嘉生物制品有限公司 含有生物活性成分的饲料添加剂
CA2281463A1 (en) * 1999-08-26 2001-02-26 Stanley H. Zlotkin Composition comprising micronutrients in combination with prebiotics, probiotics, and synbiotics
DE19958985A1 (de) * 1999-12-07 2001-06-13 Nutricia Nv Oligosaccharidmischung
EP1125507A1 (de) † 2000-02-15 2001-08-22 Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.) Inulinprodukte mit verbesserten Nahrungseigenschaften
CN1229115C (zh) * 2000-02-17 2005-11-30 惠氏公司 含有益生素物质的营养配方
US6592863B2 (en) † 2000-08-22 2003-07-15 Nestec S.A. Nutritional composition
EA006429B1 (ru) † 2001-03-09 2005-12-29 Сосьете Де Продюи Нестле С.А. Композиция для предупреждения или восстановления возрастных функциональных дефицитов у млекопитающих и способ ее применения
JP3975266B2 (ja) * 2002-05-24 2007-09-12 独立行政法人産業技術総合研究所 細胞培養装置

Also Published As

Publication number Publication date
ES2278021T3 (es) 2007-08-01
EP1243273A1 (de) 2002-09-25
DE60217319T3 (de) 2019-04-18
EP1383514B2 (de) 2018-12-19
ES2278021T5 (es) 2019-05-13
CN1738595A (zh) 2006-02-22
JP2004529910A (ja) 2004-09-30
AR033439A1 (es) 2003-12-17
ZA200308189B (en) 2005-03-30
WO2002076471A1 (en) 2002-10-03
US8092608B2 (en) 2012-01-10
CA2442053C (en) 2012-07-10
US20040219157A1 (en) 2004-11-04
EP1383514B1 (de) 2007-01-03
JP4456329B2 (ja) 2010-04-28
DE60217319D1 (de) 2007-02-15
CA2442053A1 (en) 2002-10-03
UY27221A1 (es) 2002-08-30
CN1738595B (zh) 2011-01-12
DE60217319T2 (de) 2007-10-04
EA006441B1 (ru) 2005-12-29
EA200301044A1 (ru) 2004-04-29
PE20020986A1 (es) 2003-01-02
EP1383514A1 (de) 2004-01-28

Similar Documents

Publication Publication Date Title
ATE350045T1 (de) Verwendung einer zusammensetzung mit einem prebiotischen mittel zur reduzierung des entzündlichen prozesses und der abnormalen aktivierung unspezifischer immunparameter
DE60235593D1 (de) Filter mit Teilchenverteilung zur Nachbehandlung von Abgasen
DE60301350D1 (de) Verfahren zur herstellung von 7-substituierten -3-chinolin und 3-chinol-4-on carbonitrile
DE60223832D1 (de) Härtbare organopolysiloxanzusammensetzung, verwendung des gehärteten produkts der zusammensetzung und halbleitervorrichtung
DE602004025463D1 (de) Verwendung von ciclesonide zur erhaltung des feinen teilchengrössenanteils von formoterol
EP1666118A4 (de) Keramikwabenfilter und herstellungsverfahren dafür
AU2003286657A8 (en) Filters and methods of making and using the same
ID21314A (id) Komposisi pembersih dan disinfektan yang dapat didegradasi dalam air, padat, dan metoda-metoda gabungan dari pembuatan dan penggunaannya
DE60222671D1 (de) Thienopyrimidinedione und deren verwendung in der behandlung von autoimmunerkrankungen
EP1432431A4 (de) Verfahren und zusammensetzungen zur modulierung der wirkung des interleukin-21-rezeptors
DE60221569D1 (de) Acrylsulfonamidderivate zur verwendung als ccr3-antagonisten bei der behandlung von inflammatorischen und immunologischen erkrankungen
DE60210265D1 (de) Verfahren und zwischenprodukte zur herstellung von 4-aminochinolin-cetp-inhibitoren
EP1377611A4 (de) Muteine des durch hypoxie induzierbaren faktors alpha und verwendungsverfahren dafür
NO20034864D0 (no) Preparat for behandling av legemiddelindusert forstoppelse med 15-keto-prostaglandiner
EE200300473A (et) Tsüano-asendatud dihüdropürimidiinühendid ja nende kasutamine haiguste raviks
ATE509889T1 (de) Verfahren zur herstellung von granulatförmigem umhüllten natriumpercarbonat und verfahrensgemäss erhältliches produkt
EE200300474A (et) Tsüano-asendatud dihüdropürimidiinühendid ja nende kasutamine haiguste raviks
EP1521589A4 (de) Bioaktivation von partikeln
DE50305507D1 (de) Zusammensetzungen zur herstellung von aminoplasterzeugnissen
DE69928820D1 (de) Akt zusammensetzungen zur steigerung des überlebens von kardiomyozyten
DE60223962D1 (de) Verwendung Duftstoff zurückhaltender Zusammensetzungen
DE60305081D1 (de) Fluorkautschukzusammensetzung und Gegenstand
DE50107279D1 (de) Autoklav zur präzisionsreinigung von stücken und verwendung des autoklavs
DE50103079D1 (de) Anlage zur thermischen Behandlung von mehlförmigen Rohmaterialien
DE60335344D1 (de) Styrolharzzusammensetzung und herstellungsverfahren dafür

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties